GR3023394T3 - Improvements in or relating to contrast agents - Google Patents

Improvements in or relating to contrast agents

Info

Publication number
GR3023394T3
GR3023394T3 GR970401048T GR970401048T GR3023394T3 GR 3023394 T3 GR3023394 T3 GR 3023394T3 GR 970401048 T GR970401048 T GR 970401048T GR 970401048 T GR970401048 T GR 970401048T GR 3023394 T3 GR3023394 T3 GR 3023394T3
Authority
GR
Greece
Prior art keywords
pct
contrast agents
relating
sec
date
Prior art date
Application number
GR970401048T
Other languages
Greek (el)
English (en)
Inventor
Arne Berg
Jo Klaveness
Per Strande
Lars Stubberud
Original Assignee
Holmes Michael John
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26299192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3023394(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919114565A external-priority patent/GB9114565D0/en
Priority claimed from GB929200386A external-priority patent/GB9200386D0/en
Application filed by Holmes Michael John, Nycomed Imaging As filed Critical Holmes Michael John
Publication of GR3023394T3 publication Critical patent/GR3023394T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/226—Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Acoustics & Sound (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR970401048T 1991-07-05 1997-05-09 Improvements in or relating to contrast agents GR3023394T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919114565A GB9114565D0 (en) 1991-07-05 1991-07-05 Improvements in or relating to contrast agents
GB929200386A GB9200386D0 (en) 1992-01-09 1992-01-09 Improvements in or relating to contrast agents
PCT/EP1992/001477 WO1993000930A1 (en) 1991-07-05 1992-07-03 Improvements in or relating to contrast agents

Publications (1)

Publication Number Publication Date
GR3023394T3 true GR3023394T3 (en) 1997-08-29

Family

ID=26299192

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970401048T GR3023394T3 (en) 1991-07-05 1997-05-09 Improvements in or relating to contrast agents

Country Status (15)

Country Link
US (2) US5607661A (no)
EP (1) EP0593624B1 (no)
JP (1) JPH06510758A (no)
AT (1) ATE151993T1 (no)
AU (1) AU675050B2 (no)
CA (1) CA2112109A1 (no)
DE (1) DE69219337T2 (no)
DK (1) DK0593624T3 (no)
ES (1) ES2103376T3 (no)
FI (1) FI940027A0 (no)
GR (1) GR3023394T3 (no)
HK (1) HK1006945A1 (no)
IE (1) IE80926B1 (no)
NO (1) NO940015L (no)
WO (1) WO1993000930A1 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
CA2119129C (en) * 1991-09-17 1999-11-09 Steven C. Quay Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
NZ262237A (en) * 1993-01-25 1997-06-24 Sonus Pharma Inc Ultrasound contrast agents comprising phase shift colloids having a boiling point below the body temperature of the animal it is used in
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
ES2231775T5 (es) 1993-07-30 2011-02-02 Imcor Pharmaceutical Co. Composición de microburbujas estabilizadas para ecografía.
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
US5540909A (en) * 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
US5897851A (en) * 1995-06-07 1999-04-27 Sonus Pharmaceuticals, Inc. Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
DE19602930A1 (de) * 1996-01-18 1997-07-24 Schering Ag Poröse Matrices aus niedermolekularen Substanzen zur Genierung stabiler Gasblasensuspensionen, deren Verwendung als Ultraschallkontrastmittel sowie Verfahren zu deren Herstellung
IL126073A (en) * 1996-03-05 2002-02-10 Acusphere Inc Microencapsulated fluorinated gases for use as imaging agents
GB9622711D0 (en) * 1996-10-31 1997-01-08 British Tech Group Instrument having enhanced ultrasound visibility
US6054118A (en) * 1997-01-22 2000-04-25 Nycomed Imaging As Contrast agents comprising two types of gas-containing microparticles
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
AU2683899A (en) * 1998-02-19 1999-09-06 University Of Virginia Patent Foundation The use of bjerknes forces to manipulate contrast agents
US7109167B2 (en) 2000-06-02 2006-09-19 Bracco International B.V. Compounds for targeting endothelial cells, compositions containing the same and methods for their use
JP3819845B2 (ja) * 2001-04-06 2006-09-13 ブラッコ・リサーチ・ソシエテ・アノニム 流体で充填された空洞内の局所物理パラメータの改善された測定方法
WO2004065621A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
WO2003074005A2 (en) 2002-03-01 2003-09-12 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) * 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
EP1603935A4 (en) 2003-03-03 2007-03-21 Dyax Corp SPECIFIC TO HGF RECEPTOR (cMET) BINDING PEPTIDES AND THEIR USE
SE526838C2 (sv) * 2003-11-27 2005-11-08 Xcounter Ab Undersökningsmetod och anordning för detektion av joniserande strålning
US20050255176A1 (en) * 2004-05-17 2005-11-17 Burgess W P Method for attenuating free radical formation resulting from bodily insult
US20050255175A1 (en) * 2004-05-17 2005-11-17 Burgess W P Method for protecting nephron against injury caused by disruption of a chemical environment in the kidneys
US7019035B2 (en) * 2004-05-17 2006-03-28 Md Scientific Llc Method for attenuating free radical formation resulting from bodily insult
US7625586B2 (en) 2004-10-28 2009-12-01 Md Scientific, Llc Method for mitigating injury to a kidney resulting from an ischemic event
US7999134B2 (en) * 2009-07-21 2011-08-16 Ge Healthcare As Crystallization of iodixanol using milling
US9827265B1 (en) 2012-04-06 2017-11-28 Md Scientific, Llc Method for attenuating free radical formation resulting from a bodily insult
US11471401B2 (en) 2014-08-28 2022-10-18 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
US11504322B2 (en) 2014-08-28 2022-11-22 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
SG11201701505RA (en) 2014-08-28 2017-03-30 Gen Hospital Corp Injectable slurries and methods of manufacturing and using the same
KR20180122642A (ko) 2016-02-26 2018-11-13 더 제너럴 하스피탈 코포레이션 의료용 빙류 슬러리 제조 및 전달 시스템 및 방법
JP7211699B2 (ja) * 2017-09-11 2023-01-24 バイエル ファーマ アクチエンゲゼルシャフト 超音波診断用造影剤
US11241330B1 (en) 2021-04-02 2022-02-08 Brixton Biosciences, Inc. Apparatus for creation of injectable slurry

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2680133A (en) * 1951-08-24 1954-06-01 Mallinckrodt Chemical Works Iodine-containing amino-benzoyl derivatives of amino acids
DE2629228C2 (de) * 1976-06-25 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Jodierte Isophthalamsäure-Derivate Verfahren zu deren Herstellung sowie deren Verwendung
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
DE3173476D1 (en) * 1980-11-17 1986-02-20 Schering Ag Composition generating microbubbles
US4572203A (en) * 1983-01-27 1986-02-25 Feinstein Steven B Contact agents for ultrasonic imaging
DE3313946A1 (de) * 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
DE3834705A1 (de) * 1988-10-07 1990-04-12 Schering Ag Ultraschallkontrastmittel aus gasblaeschen und fettsaeure enthaltenden mikropartikeln
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US5354549A (en) * 1987-07-24 1994-10-11 Nycomed Imaging As Iodinated esters
DE3828905A1 (de) * 1988-08-23 1990-03-15 Schering Ag Mittel bestehend aus cavitate oder clathrate bildenden wirt/gast-komplexen als kontrastmittel
GB8900376D0 (en) * 1989-01-09 1989-03-08 Nycomed As Iodinated esters
US5215680A (en) * 1990-07-10 1993-06-01 Cavitation-Control Technology, Inc. Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
US5205290A (en) * 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5233995A (en) * 1991-11-21 1993-08-10 Sterling Winthrop Inc. Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods

Also Published As

Publication number Publication date
IE80926B1 (en) 1999-06-30
EP0593624A1 (en) 1994-04-27
NO940015D0 (no) 1994-01-04
AU675050B2 (en) 1997-01-23
DE69219337T2 (de) 1997-10-09
ATE151993T1 (de) 1997-05-15
CA2112109A1 (en) 1993-01-21
AU2277292A (en) 1993-02-11
WO1993000930A1 (en) 1993-01-21
FI940027A (fi) 1994-01-04
JPH06510758A (ja) 1994-12-01
FI940027A0 (fi) 1994-01-04
HK1006945A1 (en) 1999-03-26
US5607661A (en) 1997-03-04
DK0593624T3 (da) 1997-05-20
DE69219337D1 (de) 1997-05-28
US5772984A (en) 1998-06-30
NO940015L (no) 1994-01-04
IE922179A1 (en) 1993-01-13
EP0593624B1 (en) 1997-04-23
ES2103376T3 (es) 1997-09-16

Similar Documents

Publication Publication Date Title
GR3023394T3 (en) Improvements in or relating to contrast agents
GB9415554D0 (en) Cobalt on alumina catalysts
BR9307734A (pt) Formulações injetáveis aquosas úteis para radiodiagnose compreendendo compostos aromáticos iodados usadas como meio de contraste de raio x
AU3506893A (en) Use of fullerenes in diagnostic and/or therapeutic agents
FI970920A (fi) Trifenyylietyleenejä käytettäväksi osteoporoosin ehkäisyyn ja hoitoon
DE69621596T2 (de) Antimikrobielles mittel bestehend aus gläser mit kontrollierter abgabe
FR2722506B1 (fr) Composition contenant des acides nucleiques, preparation et utilisations
PL318297A1 (en) Dihydrobenzofuranes
PL337803A1 (en) Pharmaceutic agents containing eletriptane hemisulphate and caffeine
PL310171A1 (en) Novel imidazopyridines
GR3020473T3 (en) Dermatological and/or cosmetological composition containing retinoids.
ES2118934T3 (es) Medios de contraste.
US5366722B1 (en) Contrast media comprising a non-ionic contrast agent and sodium ions
AU2320392A (en) Hydroxamate and hydrazide derivatives of polyamines and their medical use as chelating agents
GR3026324T3 (en) Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered.
MX9203100A (es) Nuevos peptidos, su preparacion y su aplicacion.
RS49734B (sr) Primena intravenoznih kontrastnih sredstava za projekcionu mamografiju
DE69319337D1 (en) Polyetheramidoamine hydrogele als heparinersatz
ES2017279A6 (es) Procedimiento para la obtencion de piperazinas y homopiperazinas substituidas.
ES2106680A1 (es) Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondiente.
WO1998023297A3 (en) Particulate compositions
DK0614457T3 (no)
JO1682B1 (en) Contrast media